ProfileGDS5822 / ILMN_1223041
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 76% 86% 81% 74% 85% 80% 81% 81% 80% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 186.876
GSM1276600PDAC Late Ablation Control 2280.986
GSM1276601PDAC Late Ablation Control 3211.681
GSM1276602PDAC Late Ablation 169.874
GSM1276603PDAC Late Ablation 2279.785
GSM1276604PDAC Late Ablation 3149.480
GSM1303940PDAC Late Ablation_anti-CTLA4 1154.581
GSM1303941PDAC Late Ablation_anti-CTLA4 2207.881
GSM1303942PDAC Late Ablation_anti-CTLA4 3188.880